Impact of patient counseling on medication adherence in respiratory tract infection patients in a tertiary care teaching hospital
Accepted: February 17, 2025
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Respiratory tract infections (RTIs) significantly impact public health in India, with high morbidity and mortality rates. Effective management of RTIs relies on medication adherence (MA), which is often challenged by factors like forgetfulness, side effects, and socioeconomic barriers. This study aimed to evaluate the impact of patient counseling on MA among RTI patients and to assess the influence of demographic, socioeconomic, and clinical factors on adherence. A cross-sectional observational study was conducted at Vivekananda General Hospital Hubballi, India, from August 2023 to January 2024, involving 200 RTI patients. MA was measured using the Medication Adherence Report Scale (MARS) before and after patient counseling. Statistical analysis assessed the effect of age, gender, comorbidities, and socioeconomic status on adherence. MA significantly improved following patient counseling, with mean MARS scores increasing from 4.13±1.601 to 6.80±1.592 (p<0.05). Age was positively correlated with adherence, while factors like gender, infection type, and socioeconomic status had varied effects. Overall, patient counseling effectively enhanced adherence across all groups. The study underscores the importance of patient counseling in improving MA among RTI patients. Personalized interventions and addressing socioeconomic barriers are crucial for optimizing treatment outcomes.
Ethics Approval
The KLE College of Pharmacy Ethical Committee gave its approval to the study (IEC Reference Number: KLECOPH/IEC/2023-24/08).How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.